BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24197886)

  • 1. Clinical comparison of Simplexa universal direct and BD GeneOhm tests for detection of toxigenic Clostridium difficile in stool samples.
    Nolte FS; Ribeiro-Nesbitt DG
    J Clin Microbiol; 2014 Jan; 52(1):281-2. PubMed ID: 24197886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.
    Deak E; Miller SA; Humphries RM
    J Clin Microbiol; 2014 Mar; 52(3):960-3. PubMed ID: 24352999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
    Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
    J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens.
    Shin BM; Mun SJ; Yoo SJ; Kuak EY
    J Clin Microbiol; 2012 Nov; 50(11):3765-7. PubMed ID: 22952270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.
    Karre T; Sloan L; Patel R; Mandrekar J; Rosenblatt J
    J Clin Microbiol; 2011 Feb; 49(2):725-7. PubMed ID: 21123537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces.
    Terhes G; Urbán E; Sóki J; Nacsa E; Nagy E
    J Clin Microbiol; 2009 Nov; 47(11):3478-81. PubMed ID: 19794052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
    Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
    J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
    Dalpke AH; Hofko M; Zorn M; Zimmermann S
    J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
    Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
    J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Verigene Clostridium difficile, Simplexa C. difficile Universal Direct, BD MAX Cdiff, and Xpert C. difficile assays for the detection of toxigenic C. difficile.
    Gilbreath JJ; Verma P; Abbott AN; Butler-Wu SM
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):13-8. PubMed ID: 25027069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.
    Boyanton BL; Sural P; Loomis CR; Pesta C; Gonzalez-Krellwitz L; Robinson-Dunn B; Riska P
    J Clin Microbiol; 2012 Mar; 50(3):640-5. PubMed ID: 22189114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.
    Hirvonen JJ; Mentula S; Kaukoranta SS
    J Clin Microbiol; 2013 Sep; 51(9):2908-12. PubMed ID: 23804386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.
    Peterson LR; Young SA; Davis TE; Wang ZX; Duncan J; Noutsios C; Liesenfeld O; Osiecki JC; Lewinski MA
    J Clin Microbiol; 2017 Dec; 55(12):3426-3436. PubMed ID: 28954901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens.
    Buchan BW; Mackey TL; Daly JA; Alger G; Denys GA; Peterson LR; Kehl SC; Ledeboer NA
    J Clin Microbiol; 2012 Dec; 50(12):3932-6. PubMed ID: 23015667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular test based on isothermal helicase-dependent amplification for detection of the Clostridium difficile toxin A gene.
    Eckert C; Holscher E; Petit A; Lalande V; Barbut F
    J Clin Microbiol; 2014 Jul; 52(7):2386-9. PubMed ID: 24759714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections.
    Lalande V; Barrault L; Wadel S; Eckert C; Petit JC; Barbut F
    J Clin Microbiol; 2011 Jul; 49(7):2714-6. PubMed ID: 21525213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual cause of false-positive results with the BD GeneOhm Cdiff assay.
    Louie L; Wong H; Mubareka S; Simor AE
    J Clin Microbiol; 2013 Apr; 51(4):1348-9. PubMed ID: 23345300
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicenter evaluation of the Quidel Lyra Direct C. difficile nucleic acid amplification assay.
    Beck ET; Buchan BW; Riebe KM; Alkins BR; Pancholi P; Granato PA; Ledeboer NA
    J Clin Microbiol; 2014 Jun; 52(6):1998-2002. PubMed ID: 24671790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.
    Stellrecht KA; Espino AA; Maceira VP; Nattanmai SM; Butt SA; Wroblewski D; Hannett GE; Musser KA
    J Clin Microbiol; 2014 May; 52(5):1423-8. PubMed ID: 24554744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.